News + Filings Transactions Holdings
All 13F 13D/G Other
|
Hoffman Michael B
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/20/2023 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Granted 6,820 options to buy
@ $13.17, valued at
$89.8k
|
|
01/05/2022 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Paid exercise price by delivering 6,658 shares
@ $19.78, valued at
$131.7k
Paid exercise price by delivering 90 shares
@ $19.78, valued at
$1.8k
Granted 9,000 options to buy
@ $19.78, valued at
$178k
Exercised 30,000 options to buy
@ $4.39, valued at
$131.7k
Exercised 7,142 options to buy
@ $0.25, valued at
$1.8k
|
|
07/09/2021 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Granted 4,500 options to buy
@ $102.85, valued at
$462.8k
|
|
08/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Bought 33,333 shares
@ $6, valued at
$200k
Converted 158,730 shares
@ $0 Converted 1,137,942 shares
@ $0 Converted 55,884 shares
@ $4.8, valued at
$268.2k
Converted 222,222 preferred shares
@ $0 Converted 1,593,118 preferred shares
@ $0 Converted 55,884 convertible notes
@ $4.8, valued at
$268.2k
|
|
07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/29/2018 |
4
| Hoffman Michael B (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Sold 20,000 shares
@ $0.4535, valued at
$9.1k
Sold 20,000 shares
@ $0.4445, valued at
$8.9k
Sold 30,000 shares
@ $0.4569, valued at
$13.7k
Sold 29,999 shares
@ $0.4507, valued at
$13.5k
|
|
07/30/2018 |
4
| Hoffman Michael B (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 87,500 options to buy
@ $0.46, valued at
$40.3k
|
|
05/01/2018 |
4
| Hoffman Michael B (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Bought 2,211,765 shares
@ $0 Bought 2,211,765 options to buy
@ $0.425, valued at
$940k
|
|
06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/10/2016 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Exercised (in-or-at-the-money) 528,845 shares
@ $4.1, valued at
$2.2M
Exercised (in-or-at-the-money) 528,845 rights
@ $4.1, valued at
$2.2M
Exercised (in-or-at-the-money) 396,633 warrants
@ $4.92, valued at
$2M
|
|
05/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/01/2013 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Converted 83,857 shares
@ $0 Converted 105,363 shares
@ $0 Converted 266,712 shares
@ $0 Converted 476,087 shares
@ $0 Converted 85,744 shares
@ $0 Converted 84,530 shares
@ $0 Converted 172,411 shares
@ $0 Converted 226,024 shares
@ $0 Converted 1,226,942 shares
@ $0 Bought 1,000,000 shares
@ $15, valued at
$15M
Converted 99,350 convertible preferred
@ $0 |
|
07/29/2013 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 13,000 options to buy
@ $15, valued at
$195k
|
|
|
|